Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (36)

1

A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients

enthalten in: Antiviral therapy | 2009

von Bouillon-Pichault, M. | Jullien, V. | Piketty, C. | +11

2

Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals

enthalten in: Antiviral therapy | 2009

von van der Lugt, J. | Lange, J. | Avihingsanon, A. | +6

3

Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone

enthalten in: Antiviral therapy | 2009

von Flandre, P. | Delaugerre, C. | Ghosn, J. | +10

4

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

enthalten in: Antiviral therapy | 2009

von Pulido, F. | Pérez-Valero, I. | Delgado, R. | +13

5

Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks

enthalten in: Antiviral therapy | 2009

von Bunupuradah, T. | van der Lugt, J. | Kosalaraksa, P. | +11

6

Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen

enthalten in: Antiviral therapy | 2009

von Azria, E. | Moutafoff, C. | Schmitz, T. | +10

7

Pharmacokinetics and tolerability of once- versus twice-daily lopinavir/ritonavir treatment in HIV-1-infected children

enthalten in: Antiviral therapy | 2009

von la Porte, C. | van Heeswijk, R. | Mitchell, C. | +3

8

Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV

enthalten in: Antiviral therapy | 2009

von Young, J. | Bucher, H. | Guenthard, H. | +8

9

Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily

enthalten in: Antiviral therapy | 2008

von van der Flier, M. | Verweel, G. | van der Knaap, L. | +5

10

Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation

enthalten in: Antiviral therapy | 2008

von Boffito, M. | Else, L. | Back, D. | +6